BioVex - Xconomy

Entry	Author	Date	Location
Amira Pharma on How it Beat the Odds, and Sold an Early Stage Drug to Bristol-Myers for $325M	Luke Timmerman	09/07/11	San Diego
Jennerex Shows that Unorthodox Cancer-Fighting Virus Can be Delivered the Usual Way	Luke Timmerman	08/31/11	San Francisco
Stop the M&A Obsession: Biotech Needs More Companies to Stay Independent	Luke Timmerman	07/18/11	National
Jennerex Shows Survival Edge for Liver Cancer Patients in Small Study of Anti-Tumor Virus	Luke Timmerman	05/19/11	San Francisco
The Resurgence of Gene and Cell Therapy	Barrie Carter	05/16/11	Seattle
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the First Quarter	Gregory T. Huang	03/31/11	Boston
Jennerex, Maker of Cancer-Fighting Virus, Says Early Data Shows Survival Benefit	Luke Timmerman	02/17/11	San Francisco
Clinical Data Stock Soars on FDA Approval, Amgen Buys BioVex, Stromedix Raises $2M, & More Boston-Area Life Sciences News	Erin Kutz	01/28/11	Boston
Seattle Genetics Manager Accused of Insider Trading, Bristol Stays in Seattle, Amgen Buys BioVex, & More Seattle-Area Life Sciences News	Luke Timmerman	01/27/11	Seattle
Amgen’s R&D Chief, Roger Perlmutter, on Why BioVex’s Cancer-Fighting Virus Is Worth $1B	Luke Timmerman	01/26/11	Boston
Myriant Gets $60M, BioVex Bought By Amgen, Raindance Wraps Up $37.5M, & More Boston-Area Deals News	Erin Kutz	01/26/11	Boston
Amgen Acquires BioVex for $1,000,000,000	VentureDeal	01/25/11	Boston
Amgen to Acquire BioVex for Up To $1B, to Obtain Cancer-Killing Virus Therapy	Luke Timmerman	01/24/11	Boston
Jennerex, Charging Ahead With Tumor-Killing Virus, Follows Biotech Road Less Traveled	Luke Timmerman	09/09/10	San Francisco
2009′s Top 10 Private Equity Deals in Massachusetts: The List	Ryan McBride	01/25/10	Boston
Bay State Venture Funding Perked Up in November: There Were Even Some Energy Deals	Robert Buderi	12/11/09	Boston
Pulmatrix Pulls in $30.2M, GenArts Gobbles Up Wondertouch, BioVex Bags $30M, & More Boston-Area Deals News	Rebecca Zacks	11/11/09	Boston
BioVex Nails Down Another $30M To Finish Pivotal Study of Cancer-Killing Virus	Luke Timmerman	11/10/09	Boston
BioVex Garners $30,000,000 Series F Funding	VentureDeal	11/10/09	Boston
Lilliputian Discovers $25M, Biovex Bags $40M, Clinical Data Cedes Cogenics to Beckman Coulter for $17M, & More Boston-Area Deals News	Rebecca Zacks	04/06/09	Boston
Genzyme Shrinks Gene Therapy Effort, Expands Oncology; BioVex Raises $40M For Cancer-Fighting Viruses; Biogen Looks to Future of MS Franchise; & More Boston-Area Life Sciences News	Rebecca Zacks	04/01/09	Boston
BioVex Raises $40M for Cancer-Fighting Virus	Luke Timmerman	03/30/09	Boston
Boston Biotechs Seek Scarce Funds Amid Market Famine at Annual Pitch Event	Ryan McBride	12/04/08	Boston
BioVex Viral Treatment Shrinks Melanoma Tumors in Trial	Luke Timmerman	06/01/08	Boston
Pfizer Picks a Local Target, Sermo Meets Satellite Radio, and the Rest of the Recent Deals	Rebecca Zacks	11/19/07	Boston
BioVex Completes $35 Million Financing	Rebecca Zacks	11/16/07	Boston
Page 1 of 1

Entry

Author

Date

Location

Amira Pharma on How it Beat the Odds, and Sold an Early Stage Drug to Bristol-Myers for $325M

Luke Timmerman

09/07/11

San Diego

Jennerex Shows that Unorthodox Cancer-Fighting Virus Can be Delivered the Usual Way

Luke Timmerman

08/31/11

San Francisco